| Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes E Bernard, Y Nannya, RP Hasserjian, SM Devlin, H Tuechler, ... Nature medicine 26 (10), 1549-1556, 2020 | 460 | 2020 |
| Cancer therapy shapes the fitness landscape of clonal hematopoiesis KL Bolton, RN Ptashkin, T Gao, L Braunstein, SM Devlin, D Kelly, M Patel, ... Nature genetics 52 (11), 1219-1226, 2020 | 436 | 2020 |
| Molecular international prognostic scoring system for myelodysplastic syndromes E Bernard, H Tuechler, PL Greenberg, RP Hasserjian, JE Arango Ossa, ... NEJM evidence 1 (7), EVIDoa2200008, 2022 | 402 | 2022 |
| Clustering of maxima: Spatial dependencies among heavy rainfall in France E Bernard, P Naveau, M Vrac, O Mestre Journal of climate 26 (20), 7929-7937, 2013 | 134 | 2013 |
| Efficient RNA isoform identification and quantification from RNA-Seq data with network flows E Bernard, L Jacob, J Mairal, JP Vert Bioinformatics 30 (17), 2447-2455, 2014 | 107 | 2014 |
| Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis T Gao, R Ptashkin, KL Bolton, M Sirenko, C Fong, B Spitzer, ... Nature communications 12 (1), 338, 2021 | 79 | 2021 |
| Unified classification and risk-stratification in acute myeloid leukemia Y Tazi, JE Arango-Ossa, Y Zhou, E Bernard, I Thomas, A Gilkes, ... Nature Communications 13 (1), 1-16, 2022 | 78 | 2022 |
| A molecular atlas of the developing ectoderm defines neural, neural crest, placode, and nonneural progenitor identity in vertebrates JL Plouhinec, S Medina-Ruiz, C Borday, E Bernard, JP Vert, MB Eisen, ... PLoS biology 15 (10), e2004045, 2017 | 56 | 2017 |
| Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma EH Rustad, K Misund, E Bernard, E Coward, VD Yellapantula, ... American journal of hematology 94 (12), 1364-1373, 2019 | 25 | 2019 |
| Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression A Kazachenka, GR Young, J Attig, C Kordella, E Lamprianidou, E Zoulia, ... Genome Medicine 11, 1-18, 2019 | 24 | 2019 |
| TP53 state dictates genome stability, clinical presentation and outcomes in myelodysplastic syndromes E Bernard, Y Nannya, T Yoshizato, RP Hasserjian, R Saiki, Y Shiozawa, ... Blood 134, 675, 2019 | 23 | 2019 |
| ZBTB33 Is Mutated in Clonal Hematopoiesis and Myelodysplastic Syndromes and Impacts RNA Splicing EM Beauchamp, M Leventhal, E Bernard, ER Hoppe, G Todisco, ... Blood cancer discovery 2 (5), 500-517, 2021 | 21 | 2021 |
| Oncologic therapy shapes the fitness landscape of clonal hematopoiesis KL Bolton, RN Ptashkin, T Gao, L Braunstein, SM Devlin, D Kelly, M Patel, ... BioRxiv, 848739, 2019 | 21 | 2019 |
| Geostrophic turbulence near rapid changes in stratification KS Smith, E Bernard Physics of Fluids 25 (4), 2013 | 20 | 2013 |
| Randomized phase II study of azacitidine±lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del (5q) B Rasmussen, G Göhring, E Bernard, L Nilsson, M Tobiasson, ... Leukemia 36 (5), 1436-1439, 2022 | 12 | 2022 |
| A convex formulation for joint RNA isoform detection and quantification from multiple RNA-seq samples E Bernard, L Jacob, J Mairal, E Viara, JP Vert BMC bioinformatics 16, 1-10, 2015 | 12 | 2015 |
| Modulation of IL-6/STAT3 signaling axis in CD4+FOXP3− T cells represents a potential antitumor mechanism of azacitidine E Lamprianidou, C Kordella, A Kazachenka, E Zoulia, E Bernard, A Filia, ... Blood Advances 5 (1), 129-142, 2021 | 11 | 2021 |
| Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms Y Nannya, M Tobiasson, S Sato, E Bernard, S Ohtake, J Takeda, ... Blood Advances 7 (14), 3624-3636, 2023 | 10 | 2023 |
| Liquid biopsies for circulating tumor DNA detection may reveal occult hematologic malignancies in patients with solid tumors M Aldea, M Tagliamento, A Bayle, D Vasseur, V Vergé, A Marinello, ... JCO precision oncology 7, e2200583, 2023 | 8 | 2023 |
| Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs G Asimomitis, AG Deslauriers, AG Kotini, E Bernard, D Esposito, ... Blood Advances 6 (10), 2992-3005, 2022 | 8 | 2022 |
Jean-Philippe VertOwkin / PSL UniversityVerified email at owkin.com
